Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Motor Imagery-Enhanced Rehabilitation Modulates Cortical Plasticity and Functional Recovery After ACL Reconstruction

20 de setembro de 2026 atualizado por: Peking University Third Hospital

Part 1: Neural Correlates of Motor Imagery in ACLR Patients This cross-sectional study aims to systematically compare differences in electroencephalographic (EEG) activity between patients who have returned to sport one year after anterior cruciate ligament reconstruction (ACLR) and healthy controls during functional tasks and associated motor imagery. We will collect EEG activity and behavioral performance data from both groups during task execution and imagination. The primary objective is to verify whether ACLR patients exhibit a specific deficit in motor imagery capability and to characterize the abnormal functional patterns within their central sensorimotor networks. By providing an objective, neurophysiological explanation for why patients struggle to return to sport, this study seeks to establish quantifiable baseline metrics for subsequent interventional research.

Part 2: Effects and Cortical Plasticity Changes Following Motor Imagery-Enhanced Rehabilitation This randomized controlled trial (RCT) combines short-term intervention with long-term follow-up to systematically evaluate the efficacy and mechanisms of motor imagery therapy in ACLR patients. The specific objectives are threefold: First, to verify the immediate effects of the intervention on enhancing neuroplasticity and restoring motor function. Second, to assess the long-term impact on definitive clinical outcomes-specifically return-to-sport rates and time to return-through a 12-month follow-up. Third, to perform a longitudinal analysis determining whether early improvements in neurophysiological indicators can predict subsequent gains in motor performance and successful return-to-sport outcomes.

Visão geral do estudo

Descrição detalhada

Part 1 employs a cross-sectional design, comparing patients one year after anterior cruciate ligament reconstruction (ACLR) (experimental group) with healthy adults (control group). This phase aims to acquire electroencephalography (EEG) and lower limb functional data across different states to elucidate the correlation between cortical function and motor behavior.

Part 2 will conduct a 12-week randomized controlled trial (RCT). ACL rupture patients will be allocated to either a motor imagery intervention group or a conventional rehabilitation control group. We will integrate EEG and kinematic analysis to systematically evaluate the therapy's effects on knee function, neuromuscular control, and brain network connectivity. Furthermore, by combining longitudinal EEG and resting-state functional magnetic resonance imaging (rs-fMRI), we will investigate the underlying neuroplastic mechanisms driving functional remodeling within the sensorimotor networks. This research is expected to establish a novel, active intervention strategy based on the "central-driven peripheral" paradigm for ACL postoperative rehabilitation.

Tipo de estudo

Intervencional

Inscrição (Estimado)

80

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

  • Nome: XIAOYUAN HAN, GRADUATE STUDENT
  • Número de telefone: 18522596808
  • E-mail: 15522650818@163.com

Locais de estudo

    • Beijing Municipality
      • Beijing, Beijing Municipality, China, 100191
        • Recrutamento
        • Peking University Third Hospital
        • Contato:

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos a 45 anos (Adulto)

Aceita Voluntários Saudáveis

Sim

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Part 1: Participants

Study Design:

  • This study will recruit 20 patients at 12 months after ACL reconstruction and 20 healthy controls.
  • Age range: 18-45 years.

Inclusion Criteria for Patient Group:

  • Age: 18-45 years old.
  • Body Mass Index (BMI): ≥18.5 kg/m² and <35 kg/m².
  • Injury Type: First-time unilateral isolated ACL rupture, reconstructed at our hospital.
  • Surgical Technique: Single-bundle hamstring tendon autograft transplantation.
  • Ligament Stability: No injury or only mild injury (Grade I) to the PCL, MCL, or LCL.
  • Postoperative Timeline: 12 months after ACL reconstruction.
  • Consent: Voluntary participation with signed informed consent.

Exclusion Criteria for Patient Group:

  • Delayed Surgery: ACL reconstruction performed >6 months after injury.
  • Combined Injuries: Severe injury (>Grade I) to PCL, MCL, or LCL; severe meniscus tear.
  • Previous Surgery: History of lower limb knee surgery (e.g., meniscus repair, arthroplasty).
  • Comorbidities: Existing knee diseases (e.g., osteoarthritis, tumors, rheumatoid arthritis, fracture).
  • Systemic/Cognitive Issues: Severe cardiac, pulmonary, cerebral disease, or hepatic/renal dysfunction; visual or cognitive impairment.
  • Imagery Ability: Score <55 on the KVIQ-20.

Inclusion Criteria for Healthy Controls:

  • Age: 18-45 years old.
  • Body Mass Index (BMI): ≥18.5 kg/m² and <35 kg/m².
  • Medical History: No history of surgery, injury, or chronic lower limb joint disease.
  • Neurological Status: No visual/cognitive impairment or neurological disorders.
  • Gait: No trauma or disease causing gait abnormalities.
  • Consent: Voluntary participation with signed informed consent.
  • Imagery Ability: Score <55 on the KVIQ-20. Study 2: Participants

Study Design:

  • This study aims to recruit 40 patients meeting the specified criteria.
  • Randomization: Participants will be randomly allocated into an experimental group (N=20) and a control group (N=20).

Inclusion Criteria for Patients:

  • Age: 18-45 years old.
  • Body Mass Index (BMI): ≥18.5 kg/m² and <35 kg/m².
  • Injury Type: First-time unilateral isolated ACL rupture, reconstructed at our hospital.
  • Surgical Technique: Single-bundle hamstring tendon autograft transplantation.
  • Ligament Stability: No injury or only mild injury (Grade I) to the PCL, MCL, or LCL.
  • Consent: Voluntary participation with signed informed consent.
  • Exclusion Criteria for Patients:
  • Delayed Surgery: ACL reconstruction performed >6 months after injury.
  • Combined Injuries: Severe injury (>Grade I) to PCL, MCL, or LCL (Grade II-III); severe meniscus tear.
  • Previous Surgery: History of lower limb knee surgery (e.g., meniscus repair, ligament reconstruction, arthroplasty).
  • Comorbidities: Existing knee diseases (e.g., osteoarthritis, tumors, rheumatoid arthritis, tuberculosis, infection).
  • Systemic/Cognitive Issues: Severe cardiac, pulmonary, cerebral disease, or hepatic/renal dysfunction; visual or cognitive impairment.
  • Imagery Ability: Score <55 on the KVIQ-20.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Tratamento
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Solteiro

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Sem intervenção: healthy adults (control group)

aims to acquire electroencephalography (EEG) and lower limb functional data across different states to elucidate the correlation between cortical function and motor behavior.

Sem intervenção: patients one year after anterior cruciate ligament reconstruction (ACLR) (experimental group)

aims to acquire electroencephalography (EEG) and lower limb functional data across different states to elucidate the correlation between cortical function and motor behavior.

Experimental: Motor Imagery Therapy group

Conventional rehabilitation augmented with motor imagery training.

Part 2 will conduct a 12-week RCT. The experimental group will receive conventional rehabilitation augmented with motor imagery training. This training will be delivered via a hybrid model (in-person and online) and consist primarily of video-guided imagery sessions.

Outros nomes:
  • Motor Simulation
  • Video-Guided Motor Imagery
Comparador Ativo: control group

receiving standard rehabilitation as the control group.

The control group received conventional rehabilitation only. During in-person sessions, they engaged in passive observation of static photographs, without any form of active mental simulation or motor rehearsal. During remote sessions, they watched the same videos as the experimental group but proceeded directly to physical practice without prior motor imagery.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
EEG delta band (0.5-4 Hz) absolute power
Prazo: Part 1 involves a cross-sectional assessment at 12 months after ACL reconstruction. Part 2 is a longitudinal study evaluating patients at four time points: preoperative baseline, 12 weeks, 6 months, and 12 months postoperatively.

Raw EEG data were collected via Smarting Pro during functional assessments.

Part 1 involves a cross-sectional assessment at 12 months after ACL reconstruction. Part 2 is a longitudinal study evaluating patients at four time points: preoperative baseline, 12 weeks, 6 months, and 12 months postoperatively.
EEG theta band (4-8 Hz) absolute power
Prazo: Part 1 involves a cross-sectional assessment at 12 months after ACL reconstruction. Part 2 is a longitudinal study evaluating patients at four time points: preoperative baseline, 12 weeks, 6 months, and 12 months postoperatively.

Raw EEG data were collected via Smarting Pro during functional assessments.

Part 1 involves a cross-sectional assessment at 12 months after ACL reconstruction. Part 2 is a longitudinal study evaluating patients at four time points: preoperative baseline, 12 weeks, 6 months, and 12 months postoperatively.
EEG alpha band (8-13 Hz) absolute power
Prazo: Part 1 involves a cross-sectional assessment at 12 months after ACL reconstruction. Part 2 is a longitudinal study evaluating patients at four time points: preoperative baseline, 12 weeks, 6 months, and 12 months postoperatively.

Raw EEG data were collected via Smarting Pro during functional assessments.

Part 1 involves a cross-sectional assessment at 12 months after ACL reconstruction. Part 2 is a longitudinal study evaluating patients at four time points: preoperative baseline, 12 weeks, 6 months, and 12 months postoperatively.
EEG beta band (13-30 Hz) absolute power
Prazo: Part 1 involves a cross-sectional assessment at 12 months after ACL reconstruction. Part 2 is a longitudinal study evaluating patients at four time points: preoperative baseline, 12 weeks, 6 months, and 12 months postoperatively.

Raw EEG data were collected via Smarting Pro during functional assessments.

Part 1 involves a cross-sectional assessment at 12 months after ACL reconstruction. Part 2 is a longitudinal study evaluating patients at four time points: preoperative baseline, 12 weeks, 6 months, and 12 months postoperatively.
EEG gamma band (30-50 Hz) absolute power
Prazo: Part 1 involves a cross-sectional assessment at 12 months after ACL reconstruction. Part 2 is a longitudinal study evaluating patients at four time points: preoperative baseline, 12 weeks, 6 months, and 12 months postoperatively.

Raw EEG data were collected via Smarting Pro during functional assessments.

Part 1 involves a cross-sectional assessment at 12 months after ACL reconstruction. Part 2 is a longitudinal study evaluating patients at four time points: preoperative baseline, 12 weeks, 6 months, and 12 months postoperatively.
Vicon 3D Gait Analysis-Spatiotemporal parameters-Gait Speed
Prazo: Part 1: cross-sectional assessment at 12 months after ACL reconstruction. Part 2: longitudinal study evaluating patients at preoperative baseline, 12 weeks, 6 months, and 12 months postoperatively.

Gait speed recorded during walking using Vicon 3D gait analysis.Unit of Measure: m/s

Part 1: cross-sectional assessment at 12 months after ACL reconstruction. Part 2: longitudinal study evaluating patients at preoperative baseline, 12 weeks, 6 months, and 12 months postoperatively.
Vicon 3D Gait Analysis-Spatiotemporal parameters-Step Length
Prazo: Part 1: cross-sectional assessment at 12 months after ACL reconstruction. Part 2: longitudinal study evaluating patients at preoperative baseline, 12 weeks, 6 months, and 12 months postoperatively.

Step length recorded during walking using Vicon 3D gait analysis.Unit of Measure: m

Part 1: cross-sectional assessment at 12 months after ACL reconstruction. Part 2: longitudinal study evaluating patients at preoperative baseline, 12 weeks, 6 months, and 12 months postoperatively.
Vicon 3D Gait Analysis-Spatiotemporal parameters-Cadence
Prazo: Part 1: cross-sectional assessment at 12 months after ACL reconstruction. Part 2: longitudinal study evaluating patients at preoperative baseline, 12 weeks, 6 months, and 12 months postoperatively.

Cadence recorded during walking using Vicon 3D gait analysis.Unit of Measure: steps/min

Part 1: cross-sectional assessment at 12 months after ACL reconstruction. Part 2: longitudinal study evaluating patients at preoperative baseline, 12 weeks, 6 months, and 12 months postoperatively.
Vicon 3D Gait Analysis-Peak Knee Flexion Angle
Prazo: Part 1 involves a cross-sectional assessment at 12 months after ACL reconstruction. Part 2 is a longitudinal study evaluating patients at four time points: preoperative baseline, 12 weeks, 6 months, and 12 months postoperatively.

Peak knee flexion angle during walking measured using Vicon 3D gait analysis. Unit of Measure: degrees

Part 1 involves a cross-sectional assessment at 12 months after ACL reconstruction. Part 2 is a longitudinal study evaluating patients at four time points: preoperative baseline, 12 weeks, 6 months, and 12 months postoperatively.
Vicon 3D Gait Analysis-Peak Knee Extension Angle
Prazo: Part 1 involves a cross-sectional assessment at 12 months after ACL reconstruction. Part 2 is a longitudinal study evaluating patients at four time points: preoperative baseline, 12 weeks, 6 months, and 12 months postoperatively.

Peak knee extension angle during walking measured using Vicon 3D gait analysis.Unit of Measure: degrees

Part 1 involves a cross-sectional assessment at 12 months after ACL reconstruction. Part 2 is a longitudinal study evaluating patients at four time points: preoperative baseline, 12 weeks, 6 months, and 12 months postoperatively.
Vicon 3D Gait Analysis-Peak Knee Abduction Angle
Prazo: Part 1 involves a cross-sectional assessment at 12 months after ACL reconstruction. Part 2 is a longitudinal study evaluating patients at four time points: preoperative baseline, 12 weeks, 6 months, and 12 months postoperatively.

Peak knee abduction angle during walking measured using Vicon 3D gait analysis.Unit of Measure: degrees

Part 1 involves a cross-sectional assessment at 12 months after ACL reconstruction. Part 2 is a longitudinal study evaluating patients at four time points: preoperative baseline, 12 weeks, 6 months, and 12 months postoperatively.
Vicon 3D Gait Analysis-Peak Knee Adduction Angle
Prazo: Part 1 involves a cross-sectional assessment at 12 months after ACL reconstruction. Part 2 is a longitudinal study evaluating patients at four time points: preoperative baseline, 12 weeks, 6 months, and 12 months postoperatively.

Peak knee adduction angle during walking measured using Vicon 3D gait analysis.Unit of Measure: degrees

Part 1 involves a cross-sectional assessment at 12 months after ACL reconstruction. Part 2 is a longitudinal study evaluating patients at four time points: preoperative baseline, 12 weeks, 6 months, and 12 months postoperatively.
Vicon 3D Gait Analysis-Ground Reaction Force - Peak at Initial Contact
Prazo: Part 1 involves a cross-sectional assessment at 12 months after ACL reconstruction. Part 2 is a longitudinal study evaluating patients at four time points: preoperative baseline, 12 weeks, 6 months, and 12 months postoperatively.

Peak vertical ground reaction force at initial contact during walking measured using Vicon 3D gait analysis.Unit of Measure: N/kg

Part 1 involves a cross-sectional assessment at 12 months after ACL reconstruction. Part 2 is a longitudinal study evaluating patients at four time points: preoperative baseline, 12 weeks, 6 months, and 12 months postoperatively.
Vicon 3D Gait Analysis-Peak Knee Flexion Moment
Prazo: Part 1 involves a cross-sectional assessment at 12 months after ACL reconstruction. Part 2 is a longitudinal study evaluating patients at four time points: preoperative baseline, 12 weeks, 6 months, and 12 months postoperatively.

Peak external knee flexion moment during walking measured using Vicon 3D gait analysis.Unit of Measure: Nm/kg

Part 1 involves a cross-sectional assessment at 12 months after ACL reconstruction. Part 2 is a longitudinal study evaluating patients at four time points: preoperative baseline, 12 weeks, 6 months, and 12 months postoperatively.
Electromyography (EMG) testing -Frequency-Domain
Prazo: Part 1 involves a cross-sectional assessment at 12 months after ACL reconstruction. Part 2 is a longitudinal study evaluating patients at four time points: preoperative baseline, 12 weeks, 6 months, and 12 months postoperatively

Surface electromyography (sEMG) signals were collected from the lower extremity muscles during the Vicon 3D gait analysis to extract frequency-domain features for muscle fatigue assessment.

Part 1 involves a cross-sectional assessment at 12 months after ACL reconstruction. Part 2 is a longitudinal study evaluating patients at four time points: preoperative baseline, 12 weeks, 6 months, and 12 months postoperatively
Electromyography (EMG) testing -Time-Domain
Prazo: Part 1 involves a cross-sectional assessment at 12 months after ACL reconstruction. Part 2 is a longitudinal study evaluating patients at four time points: preoperative baseline, 12 weeks, 6 months, and 12 months postoperatively

Surface electromyography (sEMG) signals were collected from the lower extremity muscles during the Vicon 3D gait analysis to extract time-domain features quantifying muscle activation levels.

Part 1 involves a cross-sectional assessment at 12 months after ACL reconstruction. Part 2 is a longitudinal study evaluating patients at four time points: preoperative baseline, 12 weeks, 6 months, and 12 months postoperatively
Functional Magnetic Resonance Imaging (fMRI) testing
Prazo: Part 2 includes longitudinal neuroimaging assessments. Resting-state functional magnetic resonance imaging (rs-fMRI) will be performed at preoperative baseline,6 month , and 12 months postoperatively to investigate changes in sensorimotor network conne

A subset of participants underwent task-based fMRI to identify cortical activation patterns during motor imagery.

Part 2 includes longitudinal neuroimaging assessments. Resting-state functional magnetic resonance imaging (rs-fMRI) will be performed at preoperative baseline,6 month , and 12 months postoperatively to investigate changes in sensorimotor network conne

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Isokinetic muscle strength testing
Prazo: For Part 2, assessments will be conducted at 6 and 12 months postoperatively.

Isokinetic peak torque of the quadriceps and hamstrings was measured to evaluate muscle strength symmetry between the injured and uninjured limbs.

For Part 2, assessments will be conducted at 6 and 12 months postoperatively.
Mental chronometry
Prazo: Part 1 involves a cross-sectional assessment at 12 months after ACL reconstruction. Part 2 is a longitudinal study evaluating patients at four time points: preoperative baseline, 12 weeks, 6 months, and 12 months postoperatively.

Mental chronometry was assessed to compare the imagined duration of movement with the actual execution time.

Part 1 involves a cross-sectional assessment at 12 months after ACL reconstruction. Part 2 is a longitudinal study evaluating patients at four time points: preoperative baseline, 12 weeks, 6 months, and 12 months postoperatively.
Kinesthetic and Visual Imagery Questionnaire-20
Prazo: Part 1 involves a cross-sectional assessment at 12 months after ACL reconstruction. Part 2 is a longitudinal study evaluating patients at four time points: preoperative baseline, 12 weeks, 6 months, and 12 months postoperatively.

The KVIQ-20 assesses subjective kinesthetic (body sensations) and visual (mental pictures) imagery abilities related to leg movements. The questionnaire consists of 20 items divided into two dimensions: Kinesthetic and Visual. Each item is rated on a 6-point Likert scale from 0 to 5 based on the clarity and richness of the imagery experienced. The total score ranges from 0 to 100. A higher score indicates greater imagery ability, meaning the patient can more vividly see the movement and feel the muscle/joint activity in their mind.

Part 1 involves a cross-sectional assessment at 12 months after ACL reconstruction. Part 2 is a longitudinal study evaluating patients at four time points: preoperative baseline, 12 weeks, 6 months, and 12 months postoperatively.
Tegner Activity Scale
Prazo: Part 1 involves a cross-sectional assessment at 12 months after ACL reconstruction. Part 2 is a longitudinal study evaluating patients at four time points: preoperative baseline, 12 weeks, 6 months, and 12 months postoperatively.

used to assess patients' level of physical activity and participation in sports. This scale ranges from 0 to 10, with higher scores indicating higher activity levels. A score of 0 represents disability due to knee problems (sick leave), while a score of 10 represents participation in competitive sports such as soccer or rugby at a national elite level. The scale captures both work and recreational activities, providing a comprehensive measure of functional activity beyond simple symptom relief.

Part 1 involves a cross-sectional assessment at 12 months after ACL reconstruction. Part 2 is a longitudinal study evaluating patients at four time points: preoperative baseline, 12 weeks, 6 months, and 12 months postoperatively.
Visual Analogue Score, VAS
Prazo: Part 1 involves a cross-sectional assessment at 12 months after ACL reconstruction. Part 2 is a longitudinal study evaluating patients at four time points: preoperative baseline, 12 weeks, 6 months, and 12 months postoperatively.

The Visual Analogue Scale (VAS) was used to assess patients' pain intensity at rest or during activity. The scale is typically represented as a 10 cm horizontal line, with "No pain" at one end and "Worst imaginable pain" at the other. Patients mark a point on the line corresponding to their perceived pain level, and the distance from the start is measured as the score.

Part 1 involves a cross-sectional assessment at 12 months after ACL reconstruction. Part 2 is a longitudinal study evaluating patients at four time points: preoperative baseline, 12 weeks, 6 months, and 12 months postoperatively.
International Knee Documentation Committee, IKDC
Prazo: Part 1 involves a cross-sectional assessment at 12 months after ACL reconstruction. Part 2 is a longitudinal study evaluating patients at four time points: preoperative baseline, 12 weeks, 6 months, and 12 months postoperatively.

The IKDC Subjective Knee Form was used to evaluate symptoms (pain, stiffness, swelling, locking/giving way) and functional limitations related to sports and daily activities following ACL reconstruction, as well as current knee function relative to pre-injury status. A normalized total score is calculated from these domains.

Scoring Interpretation Minimum Value: Approximately 0 points (representing severe symptoms or complete loss of function) Maximum Value: 100 points (representing no symptoms and fully normal function) Does a higher score mean a better outcome?: Yes. A higher score indicates fewer knee symptoms and better motor function and daily activity performance.

Part 1 involves a cross-sectional assessment at 12 months after ACL reconstruction. Part 2 is a longitudinal study evaluating patients at four time points: preoperative baseline, 12 weeks, 6 months, and 12 months postoperatively.
Tampa Scale for Kinesiophobia-11 (TSK-11)
Prazo: Part 1 involves a cross-sectional assessment at 12 months after ACL reconstruction. Part 2 is a longitudinal study evaluating patients at four time points: preoperative baseline, 12 weeks, 6 months, and 12 months postoperatively.

Kinesiophobia was assessed using the Tampa Scale for Kinesiophobia-11 (TSK-11). The TSK-11 is an 11-item self-report questionnaire measuring fear of movement and re-injury, rated on a 4-point Likert scale (1 = strongly disagree to 4 = strongly agree). Total scores range from 11 to 44, with higher scores indicating greater kinesiophobia. Scores reflect the severity of fear; therefore, a higher score represents a worse outcome (indicating greater fear).

Part 1 involves a cross-sectional assessment at 12 months after ACL reconstruction. Part 2 is a longitudinal study evaluating patients at four time points: preoperative baseline, 12 weeks, 6 months, and 12 months postoperatively.

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

15 de junho de 2026

Conclusão Primária (Estimado)

10 de agosto de 2027

Conclusão do estudo (Estimado)

10 de agosto de 2027

Datas de inscrição no estudo

Enviado pela primeira vez

9 de junho de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

20 de setembro de 2026

Primeira postagem (Real)

22 de setembro de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

22 de setembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

20 de setembro de 2026

Última verificação

1 de maio de 2026

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • M20260516

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever